rs201892814
Variant summary
Our verdict is Pathogenic. The variant received 8 ACMG points: 8P and 0B. PP1_ModeratePP4_ModeratePM3PVS1_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_000070.3: c.1746-20C>G variant occurs in intron 13 of the CAPN3 gene. The filtering allele frequency for this variant is 0.006051 in gnomAD v2.1.1 European (non-Finnish) genomes (the lower threshold of the 95% CI of 172/31388), which is higher than the LGMD VCEP threshold of 0.001 for BS1; in total, three homozygous individuals are also observed. However, this variant may act as a hypomorphic allele, and the VCEP opted not to apply this code (BS1 exception). RNAseq/cDNA analysis of muscle from patients carrying one copy of the variant suggests that it results in aberrant splicing, the inclusion of various portions of intron 13, and premature truncation (PMID:20635405, 35731190). An earlier study concluded the variant does not affect splicing (PMID:17979987); however, later investigations showed that the aberrantly spliced transcripts are variably expressed and not always detectable even when splicing-specific PCR is used, possibly due to nonsense-mediated mRNA decay (PMID:20635405) (PVS1_RNA_Moderate). The c.1746-20C>G variant has been detected with a second CAPN3 variant in at least 34 individuals with LGMD (PMID:37589857, 20635405, 17979987, 17157502, 35731190), including confirmed in trans with a pathogenic variant in five cases (c.550delA p.(Thr184ArgfsTer36), 4.0 pts, PMID:20635405, 35731190; c.643_663del p.(Ser215_Gly221del): 1.0 pt, PMID:35731190) (PM3_Very Strong). The variant was also reported to co-segregate with autosomal recessive disease in four affected family members from three families (PP1_Moderate; PMID:37589857, 20635405, 35731190). Several patients with the c.1746-20C>G variant and a second CAPN3 variant displayed progressive limb girdle muscle weakness or clinical suspicion of limb-girdle muscular dystrophy as well as significantly reduced or absent expression of calpain-3, which is specific for CAPN3-related LGMD (PP4_Moderate; PMID:20635405). While two homozygous patients with a mild phenotype have been reported (PMID:35731190), the number of apparently unaffected homozygous individuals described and present in population databases suggests this variant may show reduced penetrance in the homozygous state. In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/09/2025): PVS1_RNA_Moderate, PM3_Very Strong, PP1_Moderate, PP4_Moderate. The LGMD VCEP recommends careful correlation with patient phenotype and family history as well as consideration of the combined functional impact of both CAPN3 alleles when the c.1746-20C>G variant is detected in an individual with signs of limb girdle muscular dystrophy. LINK:https://erepo.genome.network/evrepo/ui/classification/CA220343/MONDO:0015152/187
Frequency
Consequence
NM_000070.3 intron
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy, limb-girdle, autosomal dominantInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)
- limb-girdle muscular dystrophyInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal dominant 4Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000070.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CAPN3 | TSL:1 MANE Select | c.1746-20C>G | intron | N/A | ENSP00000380349.3 | P20807-1 | |||
| CAPN3 | TSL:1 | c.1746-20C>G | intron | N/A | ENSP00000350181.3 | P20807-3 | |||
| CAPN3 | TSL:1 | c.1602-20C>G | intron | N/A | ENSP00000183936.4 | P20807-2 |
Frequencies
GnomAD3 genomes AF: 0.00309 AC: 470AN: 152174Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00315 AC: 791AN: 251486 AF XY: 0.00324 show subpopulations
GnomAD4 exome AF: 0.00311 AC: 4534AN: 1460084Hom.: 14 Cov.: 30 AF XY: 0.00312 AC XY: 2268AN XY: 726476 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00309 AC: 470AN: 152292Hom.: 1 Cov.: 32 AF XY: 0.00314 AC XY: 234AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at